Search Results – Inserm Transfert

Our Technology Offers

Welcome to our Technology Offers website

You want access to an innovative offer which is based on the excellence of Inserm, the leading academic research and clinical institute dedicated to human health in Europe? Find out our technologies offers of patents and research tools: here is a sample of our patents.

BIO23308-D1

Biomarker Field of development:

Genito Urinary System Therapy Area:

Biomarker Type of patent:

Methods and kits for diagnosing cause of nephrotic syndrome and

The present invention describes the identification of a soluble glomerular permeability factor, anti-Vasorin (or anti-VASN) autoantibodies synthesized […]

BIO22461-D1

Biomarker Field of development:

Genito Urinary System Therapy Area:

Biomarker Type of patent:

New prognostic method of kidney failure

The present invention relates to the prediction of kidney injury. In this study, the inventors studied the transcriptomic landscape in AAV-GN to find […]

BIO22440-D1

Biomarker Field of development:

Genito Urinary System Therapy Area:

Biomarker Type of patent:

Vasorin as a biomarker and biotarget in nephrology

Aiming to identify factors underlying podocytes loss, the inventors revealed a markedly decreased expression of Vasorin (VASN) using comparative deep […]

BIO10870-D1

Biomarker Field of development:

Genito Urinary System Therapy Area:

Biomarker Type of patent:

Ngal as a biomarker for predicting the evolution and treatment of

The severity of renal lesions after nephron reduction varied substantially among mouse strains and required activation of EGFR. Lipocalin 2 (Lcn2, […]

BIO19208-D1

Biomarker Field of development:

Genito Urinary System Therapy Area:

Biomarker Type of patent:

Cd9 as a new biomarker for diagnosing or predicting risk of

The mechanisms driving the development of extracapillary lesions in focal segmental glomerulosclerosis (FSGS) and crescentic glomerulonephritis (CGN) […]

BIO19208-T1

Drug Field of development:

Genito Urinary System Therapy Area:

Biomarker Type of patent:

Use of cd9 as a biomarker and as a biotarget in glomerulonephritis

The mechanisms driving the development of extracapillary lesions in focal segmental glomerulosclerosis (FSGS) and crescentic glomerulonephritis (CGN) […]

BIO10870-T1

Drug Field of development:

Genito Urinary System Therapy Area:

Target Type of patent:

Ngal as a novel target for the treatment of chronic kidney disease

The severity of renal lesions after nephron reduction varied substantially among mouse strains and required activation of EGFR. Lipocalin 2 (Lcn2, […]

BIO13363-T1

Drug Field of development:

Genito Urinary System Therapy Area:

Target Type of patent:

Ppar-gamma agonist as target for the treatment of rapidly progressive

This study demonstrates the pivotal role of the local PPAR-gamma agonist system in maintaining podocyte quiescence and orchestrating the global […]

147

56

310

46

Our Technology Offers

Methods and kits for diagnosing cause of nephrotic syndrome and

New prognostic method of kidney failure

Vasorin as a biomarker and biotarget in nephrology

Ngal as a biomarker for predicting the evolution and treatment of

Cd9 as a new biomarker for diagnosing or predicting risk of

Use of cd9 as a biomarker and as a biotarget in glomerulonephritis

Ngal as a novel target for the treatment of chronic kidney disease

Ppar-gamma agonist as target for the treatment of rapidly progressive

You might also be interested in

Methods of treating familial adenomatous polyposis

Engraftment of engineered mesenchymal stromal

Composition comprising furin-inhibited car

Methods and pharmaceutical compositions for

Inhibitor of the heterochromatin protein 1 (hp1)

Methods and pharmaceutical compositions for

Method for treating cancer

Methods of treating cancer combining uros

Garp as a biomarker and biotarget in t-cell

Methods for the diagnosis and treatment of t

Methods and pharmaceutical composition for

Methods for the diagnosis and treatment of acute